Option Care Jumps 20% on $5 Billion McKesson-CD&R Buyout Talks
Updated
Updated · CNBC · Oct 6
Option Care Jumps 20% on $5 Billion McKesson-CD&R Buyout Talks
3 articles · Updated · CNBC · Oct 6
Summary
Option Care Health shares surged more than 20% before the bell after the Financial Times reported McKesson and Clayton Dubilier & Rice are in advanced talks to buy the infusion services provider.
The potential transaction is valued at more than $5 billion and would pair drug distributor McKesson with private equity firm CD&R in a joint acquisition.
McKesson shares also rose 1.5%, signaling a positive early market read on the reported deal even as broader premarket movers were driven by separate analyst calls and corporate updates.